|
Sex |
Age |
Disease |
stem cell source |
Donor |
HLA mismatch |
Conditioning |
ATG |
relapse/progression |
aGVHD |
cGVHD |
| no reactivation |
1 |
F |
47,3 |
AML |
PB |
Unrelated |
- |
NMA |
- |
- |
II - IV |
- |
| 2 |
M |
43,8 |
AML |
PB |
Related |
- |
NMA |
- |
6 months |
II - IV |
Extensive |
| 3 |
M |
22,6 |
ALL |
PB |
unrelated |
- |
MA |
Yes |
- |
none - I |
Limited |
| 4 |
M |
52,3 |
NHL |
PB |
Related |
Yes |
NMA |
Yes |
- |
none - I |
Limited |
| low reactivation |
5 |
F |
32,1 |
AML |
PB |
Unrelated |
- |
MA |
Yes |
- |
none - I |
- |
| 6 |
M |
28,4 |
ALL |
PB |
Unrelated |
- |
NMA |
Yes |
- |
none - I |
Extensive |
| 7 |
M |
47,9 |
MM |
PB |
Unrelated |
- |
NMA |
Yes |
14 months |
none - I |
- |
| 8 |
M |
59,3 |
AML |
PB |
Unrelated |
Yes |
NMA |
Yes |
< 1 month |
II - IV |
Extensive |
| high reactivation |
9 |
M |
44,3 |
AML |
PB |
Related |
- |
MA |
- |
- |
none - I |
Extensive |
| 10 |
M |
18,8 |
NHL |
PB |
Unrelated |
- |
NMA |
Yes |
- |
none - I |
- |
| 11 |
M |
57,1 |
NHL |
PB |
Unrelated |
- |
NMA |
Yes |
- |
none - I |
Limited |
| 12 |
M |
51,8 |
NHL |
PB |
Related |
- |
NMA |
- |
< 1 month |
II - IV |
Extensive |
| Abbreviations: AML: Acute Myeloid Leukemia; ALL: Acute Lymphoid Leukemia; NHL: Non Hodgkin Lymphoma; MM: Multiple Myeloma; PB: Peripheral Blood; NMA: Non-Myeloablative; MA: Myeloablative; ATG: Antithymocyte Globulin; aGVHD: Acute Graft Versus Host Disease; cGVHD: Chronic Graft Versus Host Disease. |
|
